Proteon Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PRTO and buy or sell other stocks, options, and ETFs commission-free!

About PRTO

Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. 

CEO
Timothy P. Noyes, MBA
CEOTimothy P. Noyes, MBA
Employees
27
Employees27
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2001
Founded2001
Employees
27
Employees27

PRTO Key Statistics

Market cap
326.06M
Market cap326.06M
Price-Earnings ratio
-1.12
Price-Earnings ratio-1.12
Dividend yield
Dividend yield
Average volume
96.76K
Average volume96.76K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$4.95
52 Week high$4.95
52 Week low
$1.04
52 Week low$1.04
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.